Industry Supporter Program

Industry Supporter Program


​Wednesday, February 14

ABBOTT - 14:30 -16:00 Hall B
FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM
DRIVING CLINICAL OUTCOMES – RCTS, REGISTRIES AND THE REAL WORLD

Chair: Thomas Pieber, M.D. Medical University of Graz, Graz (Austria)

SELFY and IMPACT - Improved clinical outcomes in teens and young adults 
Fiona Campbell, M.D. University of Leeds, Leeds (UK)

Insights from the DPV registry - Benefts of the FreeStyle Libre system in a paediatric population
Thomas Danne, M.D. Auf der Bult Hospital for Children and Adolescents,Hannover (Germany)

Real world analysis - Longitudinal data from FreeStyle Libre system users 
Ramzi Ajjan, M.D. University of Leeds, Leeds (UK)

Panel discussion
Thomas Pieber, M.D. and all presenters

MEDTRONIC 14:30-16:00 Hall L3
BEYOND HBA1C: CGM ENHANCES THERAPEUTIC CHOICE, PATIENT EMPOWERMENT, SHARED DECISION-MAKING AND REDUCES HEALTHCARE COSTS

Prof Robert Vigersky (USA)
Prof Rogerio Ribeiro (Portugal)

ASCENSIA DIABETES CARE 14:30-16:00 Hall N
BGM AND CGM IS THERE ONLY ONE FUTURE?

Glucose Monitoring Today - Market Insights
Adam Brown, Close Concerns

Glucose Monitoring - Real Life Considerations
Dr. Guido Freckmann MD, Institute of Diabetes Technology

MARD - Looking Behind the Number
Dr. Marc D. Breton PhD, Center for Diabetes Technologies University of Virginia

The Importance of Accurate BGM for Artificial Pancreas
Dr. Steven Russell MD PhD, Massachusetts General Hospital Diabetes Research Center

Panel Discussion
Professor Lutz Heinemann PhD, Science Consulting in Diabetes

ROCHE DIABETES CARE 16:15-17:45 Hall B
ADVANCING INTEGRATED DIABETES MANAGEMENT –  A PARADIGM SHIFT FOR PEOPLE WITH DIABETES, PHYSICIANS AND PROVIDERS

Chairs: Bernhard Ludvik (Austria)
Rolf Hinzmann , Roche Diabetes Care (Germany)

The PDM ProValue Study Program shows innovative ways for integrated diabetes management
Bernd Kulzer (Germany)

MySugr: A digital solution to optimize integrated diabetes management
Anton Kittelberger (Austria)

Accu-Chek® View: How to achieve lifestyle changes and weight loss in pre-diabetes
Johann Heinrich Arens (Germany)

Inaccuracy in blood glucose monitoring: The financial impact on healthcare systems
Enrique Campos-Náñez (USA)

MEDTRONIC 16:15-17:45 Hall L3
MINIMED™ 640G SYSTEM: MAXIMIZING THE POWER OF SMARTGUARD™ TECHNOLOGY TO INCREASE TIME IN RANGE

Prof Emanuele Bosi (Italy)
Prof Robert Vigersky (USA)

MEDTRONIC 16:15-17:45 Hall N
IMPROVING PATIENTS’ EXPERIENCE WITH INSULIN INFUSION AND INJECTION PORT SOLUTIONS: A HANDS-ON SESSION TO DISCOVER THE USE OF MINIMED™ MIO™ ADVANCE AND I-PORT ADVANCE™ INJECTION PORT TO BENEFT YOUR PATIENTS.

Dr Carine de Beaufort (Luxembourg)
Mrs Geraldine Gallen (UK)
Mrs Emma Day (UK)

DREAMED DIABETES 16:15-17:45 Hall M
 3 TIPS FOR A SMART CLINIC & BEYOND
           
The 4 P’s of the Future of Medicine
Ms. Oranit Ido, Marketing and Strategy Director, DreaMed Diabetes
           
3  Practical Steps for Diabetes Data Analysis
Dr Revital Nimri Founder & Chief Medical R&D Officer, DreaMed Diabetes
           
Advisor: Deeper Analytics, Faster Insight and More Independence     
Eran Atlas Founder and CEO, DreaMed Diabetes  
 
A Clinical Case Study
Dr Revital Nimri Founder & Chief Medical R&D Officer, DreaMed Diabetes
 
Hands-On Advisor: Team Reviews of Your Real-World Cases


Thursday, February 15

DREAMED DIABETES 09:30-10:00 Hall A
WHAT'S NEXT: ASK YOUR PERSONAL ADVISOR

Chaired by, Professor Moshe Phillip, Schneider Children’s Medical Center

Ubiquitous Diabetes Data Management
Rick Altinger , CEO Glooko 

Advisor is Getting Results
Eran Atlas Founder and CEO, DreaMed Diabetes

The MD-Logic Artificial Intelligence in Clinical Use
Professor Dr. Tadej Battelino  University Children's Hospital Ljubljana, Slovenia
Professor Dr. Thomas Danne  Auf der Bult Hospital for Children and Adolescents,Hannover (Germany)

MEDTRONIC 10:30-12:00 Hall A
USING TECHNOLOGY TO INCREASE TIME IN RANGE, THE NEW GOAL FOR GLYCEMIC CONTROL

Chair: Dr. Tadej Battelino (Slovenia)

Time in Range: the emerging metric for glycemic control
Dr. Pratik Choudhary (UK)

Predictive algorithms to enhance Time In Range
Prof. Ohad Cohen (Israel)

Hybrid Closed Loop Achievements in increasing Time In Range
Dr. Francine Kaufman (USA)

MEDTRONIC 13:00-14:30 Hall L3
GUARDIAN™ CONNECT CGM: WHY PREDICTION, EDUCATION AND DATA INTERPRETATION ARE KEY FOR SUSTAINED BETTER OUTCOMES

Dr Ohad Cohen (Israel)
Dr Andrea Scaramuzza (Italy)
Mr Laurent Barsin (Switzerland)

DEXCOM 13:00-14:30 Hall C
DEXCOM CGM CONTINUATIONS AS THE CATEGORY LEADER – Updates to Clinical Study Outcomes, Future Technology and Advancements in Automated Insulin Delivery and Decision Support

IHART CGM:  The Differences Between CGM and FGM in Hypoglycemia Reduction and Improved Glycemic Control with Type 1 High Risk Patients
Prof. Nick Oliver BSc, MBBS, FRCP; Imperial College London (UK)

Dexcom’s New Platform of CGM Technology:  Review of Dexcom G6 and Future Technology
Jake Leach, Sr. Vice President Research and Development; Dexcom, Inc. San Diego, CA (USA)

Dexcom CGM and Progress Toward a Full-Closed Loop System:  Updates with Automated Insulin Delivery Study Outcomes and Decision Support Algorithms
Prof. Boris Kovatchev, PhD; University of Virginia, School of Medicine; Charlottesville, Virginia (USA)

NOVO NORDISK 15:00-16:30 Hall A
MOVING TOWARDS THE IDEAL INSULIN FOR PUMPS

Chair: Athena Philis-Tsimikas (USA)

Pursuing ultra-fast insulins for pumps
Eric Zijlstra (Germany)

Clinical data for ultra-fast insulins
David Russell-Jones (UK)

Smart technology for type 1 diabetes self-care
Eda Cengiz (USA)

Friday, February 16

CELLNOVO 08:00-08:50 ​Hall B
THE CELLNOVO SYSTEM:REAL LIFE EXPERIENCE AND FUTURE INNOVATION

Chair: Boris Kovatchev, PhD, University of Virginia, Charlottesville, Virginia (USA)

An Introduction to the Cellnovo Mobile Diabetes Management System
Dr. Julian Shapley, Chief Science Officer and Founder of Cellnovo (UK)

Clinical Characteristics and Glycaemic Outcomes: Analysis of Data from Cellnovo Online Platform
Dr. Olivia Hautier-Suply, MD (Diabetes), Medical Affairs Manager, Cellnovo (France)

Real-life experience of the Cellnovo System: The clinician and user perspective
Peter Kelly RN, Diabetes Specialist Nurse, Derriford Hospital, Plymouth (UK)

Round Table: The Cellnovo System: a platform for Future Innovation
Moderator: Dr. Julian Shapley, Chief Science Officer and Founder of Cellnovo (UK)

BD 09:40-10:00 Hall N
UNCOVERING THE HIDDEN VARIABLES IN USER INJECTION TECHNIQUE

Dr. Ronald Pettis, Principal Scientist / Director Parenteral Sciences (USA)

MEDTRONIC 09:00-10:00 Hall L3
HbA1C REDUCTION: IMPACT OF CSII IN TYPE 2 DIABETES MANAGEMENT

Prof John Pickup (UK)

ROCHE DIABETES CARE ​10:30-12:00 Hall A
FIT FOR THE FUTURE -  MERGING TECHNOLOGY AND DIGITAL SOLUTIONS FOR INTEGRATED DIABETES MANAGEMENT

Welcome and Introduction
Chairs: Julia Mader (Austria)
Rolf Hinzmann (Roche Diabetes Care, Germany)

The door to the Artificial Pancreas is wide open
Aaron Kowalski (USA)

Integrated diabetes management – where are we today and what can we expect in the future?
Marcel Gmünder (Roche Diabetes Care, Switzerland)

The Eversense® implantable CGM system – introducing the latest advance in glucose monitoring
Lynne Kelley (USA)

Driving digital health in diabetes forward - increasing time in range in personalized diabetes management

Tim Jürgens (Roche Diabetes Care, Spain)



Wrap Up and Closing Remark

SANOFI 15:00-16:30 Hall A
CASTING NEW LIGHT ON BASAL INSULIN
Chair: Luigi Meneghini

Evolution of glucose monitoring: following the course of glycemic variability
David Maahs

Stability matters: the patient journey on basal insulin
Jeremy Pettus / Lucia Novak

Evidence from the real world: a closer look at second generation basal insulins
Luigi Meneghini / Lucia Novak

Q&A and closing remarks

INSULET 16:40-18:00 Hall M
THE OMNIPOD®INSULIN MANAGEMENT SYSTEM: REAL-WORLD USE AND FUTURE INNOVATION

- Introduction to Insulet's Innovation Control
- Omnipod® Horizon™ Automated Glucose Control Clinical Trials Update
- US Population Data on Insulin Treatment and Glucose Patterns

Clinical Outcomes from the German/Austrian DPV Registry
Dr. Thomas Danne (Germany)

Clinical Outcomes for Different Insulin
Pumps: The Manchester UK Experience
Dr. Lalantha Leelarathna (UK)

DEXCOM 16:40 -18:10 Hall L6
INTRODUCTION TO DEXCOM'S DATA PHILOSOPHY AND PORTFOLIO

Annika Jimenez, Sr. Vice President Data
Dexcom, Inc. San Diego, CA; USA

Dexcom Clarity and Clarity Mobile – Leading with Retrospective Glucose Pattern Analysis and Insights
Gary Cohen, Senior Director Portland Software Center of Excellence
Dexcom, Inc. San Diego, CA; USA

Case Studies and Practical Application of Dexcom Clarity and Clarity Mobile
Keri J. Leone, MS, RD, CDE, Sr. Director, Global Professional Education
Dexcom, Inc. San Diego, CA; USA

Keep Me Updated